174 related articles for article (PubMed ID: 37108861)
1. Incidence of
Chiu CY; Ching PR
J Fungi (Basel); 2023 Mar; 9(4):. PubMed ID: 37108861
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study.
Awad WB; Asaad A; Al-Yasein N; Najjar R
BMC Infect Dis; 2020 Jun; 20(1):400. PubMed ID: 32503449
[TBL] [Abstract][Full Text] [Related]
3. Intravenous pentamidine for Pneumocystis carinii/jiroveci pneumonia prophylaxis in pediatric transplant patients.
Clark A; Hemmelgarn T; Danziger-Isakov L; Teusink A
Pediatr Transplant; 2015 May; 19(3):326-31. PubMed ID: 25712369
[TBL] [Abstract][Full Text] [Related]
4. Higher risk of urinary tract infections in renal transplant recipients receiving pentamidine versus trimethoprim-sulfamethoxazole (TMP-SMX) for Pneumocystis pneumonia prophylaxis.
Fu W; Barahona M; Harkness T; Cohen E; Reardon D; Yoo PS
Clin Transplant; 2020 Nov; 34(11):e14067. PubMed ID: 32810885
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of intravenous pentamidine for Pneumocystis jirovecii pneumonia prophylaxis in adult patients with hematologic malignancies-its utility during respiratory virus pandemics.
Liew YX; Ho AYL; Wong GC; Chung SJ; Tan TT; Tan BH
Int J Infect Dis; 2024 Jun; 143():107059. PubMed ID: 38615824
[TBL] [Abstract][Full Text] [Related]
6. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y
J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
[TBL] [Abstract][Full Text] [Related]
7. The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patients.
Kruizinga MD; Bresters D; Smiers FJ; Lankester AC; Bredius RGM
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28074607
[TBL] [Abstract][Full Text] [Related]
8. Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy.
Quinn M; Fannin JT; Sciasci J; Bragg A; Campbell PK; Carias D; Crews KR; Gregornik D; Jeha S; Maron G; Pauley JL; Swanson HD; Wolf J; Greene W
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866879
[No Abstract] [Full Text] [Related]
9. Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients.
Kim SY; Dabb AA; Glenn DJ; Snyder KM; Chuk MK; Loeb DM
Pediatr Blood Cancer; 2008 Apr; 50(4):779-83. PubMed ID: 17635000
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
11. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
12. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
Diri R; Anwer F; Yeager A; Krishnadasan R; McBride A
Transpl Infect Dis; 2016 Feb; 18(1):63-9. PubMed ID: 26606757
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
Green H; Paul M; Vidal L; Leibovici L
Cochrane Database Syst Rev; 2007 Jul; (3):CD005590. PubMed ID: 17636808
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study.
Yamashita K; Shimomura Y; Ikesue H; Muroi N; Yoshimoto A; Hashida T
BMC Infect Dis; 2021 Jul; 21(1):664. PubMed ID: 34238239
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
[TBL] [Abstract][Full Text] [Related]
16. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
17. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.
Carr A; Tindall B; Penny R; Cooper DA
AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714
[TBL] [Abstract][Full Text] [Related]
18. Risk factors associated with increased discontinuation rate of trimethoprim-sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort study.
Otani T; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Iwamoto H; Hirata S; Fujitaka K; Hamada H; Sugiyama E; Hattori N
Pulm Pharmacol Ther; 2021 Apr; 67():101999. PubMed ID: 33571651
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis jirovecii pneumonia prophylaxis in allogeneic hematopoietic cell transplant recipients: can we always follow the guidelines?
Redjoul R; Robin C; Foulet F; Leclerc M; Beckerich F; Cabanne L; di Blasi R; Pautas C; Toma A; Botterel F; Maury S; Cordonnier C
Bone Marrow Transplant; 2019 Jul; 54(7):1082-1088. PubMed ID: 30413810
[TBL] [Abstract][Full Text] [Related]
20. Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
Vasconcelles MJ; Bernardo MV; King C; Weller EA; Antin JH
Biol Blood Marrow Transplant; 2000; 6(1):35-43. PubMed ID: 10707997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
